BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25044636)

  • 1. Clinical and molecular characteristics of Chinese patients with X-linked lymphoproliferative syndrome type 1.
    An YF; Luo XB; Yang X; Wang J; Li L; Zhao XD
    Pediatr Blood Cancer; 2014 Nov; 61(11):2043-7. PubMed ID: 25044636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry.
    Zhao M; Kanegane H; Kobayashi C; Nakazawa Y; Ishii E; Kasai M; Terui K; Gocho Y; Imai K; Kiyasu J; Nonoyama S; Miyawaki T
    Cytometry B Clin Cytom; 2011 Jan; 80(1):8-13. PubMed ID: 20632414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic.
    Xu T; Zhao Q; Li W; Chen X; Xue X; Chen Z; Du X; Bai X; Zhao Q; Zhou L; Tang X; Yang X; Kanegane H; Zhao X
    Eur J Pediatr; 2020 Feb; 179(2):327-338. PubMed ID: 31754776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic and proteinic analysis of a Chinese boy with X-linked lymphoproliferative disease and his maternal relatives].
    Yang X; Wang J; An YF; Kanegane H; Miyawaki T; Zhao XD
    Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):416-20. PubMed ID: 21924052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing XLP1 in patients with hemophagocytic lymphohistiocytosis.
    Meazza R; Tuberosa C; Cetica V; Falco M; Parolini S; Grieve S; Griffiths GM; Sieni E; Marcenaro S; Micalizzi C; Montin D; Fagioli F; Moretta A; Mingari MC; Moretta L; Notarangelo LD; Bottino C; Aricò M; Pende D
    J Allergy Clin Immunol; 2014 Dec; 134(6):1381-1387.e7. PubMed ID: 24985396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature.
    Jin YY; Zhou W; Tian ZQ; Chen TX
    Hum Immunol; 2016 Aug; 77(8):658-666. PubMed ID: 27288720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and genetic features of 5 Chinese patients with X-linked lymphoproliferative syndrome.
    Sun J; Ying W; Liu D; Hui X; Yu Y; Wang J; Wang X
    Scand J Immunol; 2013 Nov; 78(5):463-7. PubMed ID: 23944711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detection.
    Shinozaki K; Kanegane H; Matsukura H; Sumazaki R; Tsuchida M; Makita M; Kimoto Y; Kanai R; Tsumura K; Kondoh T; Moriuchi H; Miyawaki T
    Int Immunol; 2002 Oct; 14(10):1215-23. PubMed ID: 12356686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.
    Booth C; Gilmour KC; Veys P; Gennery AR; Slatter MA; Chapel H; Heath PT; Steward CG; Smith O; O'Meara A; Kerrigan H; Mahlaoui N; Cavazzana-Calvo M; Fischer A; Moshous D; Blanche S; Pachlopnik Schmid J; Latour S; de Saint-Basile G; Albert M; Notheis G; Rieber N; Strahm B; Ritterbusch H; Lankester A; Hartwig NG; Meyts I; Plebani A; Soresina A; Finocchi A; Pignata C; Cirillo E; Bonanomi S; Peters C; Kalwak K; Pasic S; Sedlacek P; Jazbec J; Kanegane H; Nichols KE; Hanson IC; Kapoor N; Haddad E; Cowan M; Choo S; Smart J; Arkwright PD; Gaspar HB
    Blood; 2011 Jan; 117(1):53-62. PubMed ID: 20926771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two families of X-linked lymphoproliferative disease type 1 characterized by agammaglobulinemia].
    Li WY; Chen JS; Zhao Q; Dai RX; Wang YP; Zhao HY; Chen XM; Xue XH; Sun XY; Tang XM; Zhang Y; Ding Y; Zhao XD; Zhang ZY
    Zhonghua Er Ke Za Zhi; 2017 May; 55(5):377-382. PubMed ID: 28482391
    [No Abstract]   [Full Text] [Related]  

  • 11. No mutations of SAP/SH2D1A/DSHP and perforin genes in patients with Epstein-Barr virus-associated hemophagocytic syndrome in Japan.
    Ma X; Okamura A; Yosioka M; Ishiguro N; Kikuta H; Kobayashi K
    J Med Virol; 2001 Oct; 65(2):358-61. PubMed ID: 11536244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency.
    Marsh RA; Bleesing JJ; Filipovich AH
    J Immunol Methods; 2010 Oct; 362(1-2):1-9. PubMed ID: 20816973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical flow cytometric screening of SAP and XIAP expression accurately identifies patients with SH2D1A and XIAP/BIRC4 mutations.
    Gifford CE; Weingartner E; Villanueva J; Johnson J; Zhang K; Filipovich AH; Bleesing JJ; Marsh RA
    Cytometry B Clin Cytom; 2014 Jul; 86(4):263-71. PubMed ID: 24616127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members.
    Tabata Y; Villanueva J; Lee SM; Zhang K; Kanegane H; Miyawaki T; Sumegi J; Filipovich AH
    Blood; 2005 Apr; 105(8):3066-71. PubMed ID: 15632210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Report: Meningoencephalitis With Thrombotic Occlusive Vasculopathy in a Young EBV-Naïve Boy Is Associated With a Novel
    Steininger J; Rossmanith R; Geier CB; Leiss-Piller A; Thonhauser L; Weiss S; Hainfellner JA; Freilinger M; Schmidt WM; Eibl MM; Wolf HM
    Front Immunol; 2021; 12():747738. PubMed ID: 34987501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exon skipping caused by a complex structural variation in SH2D1A resulted in X-linked lymphoproliferative syndrome type 1.
    Wu L; Yang F; Wang J; Yang F; Liang M; Yang H
    Mol Genet Genomic Med; 2022 Mar; 10(3):e1873. PubMed ID: 35092357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A unique clinical presentation of X-linked lymphoproliferative syndrome with a novel mutation in SH2D1A and review of the literature.
    Eckrich MJ; Yang E; Domm J; Ho R; Calder C; Manes B; Bleesing J; Frangoul H
    J Pediatr Hematol Oncol; 2011 Jan; 33(1):e39-42. PubMed ID: 20975587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic challenges for a novel SH2D1A mutation associated with X-linked lymphoproliferative disease.
    Torralba-Raga L; Tesi B; Chiang SCC; Schlums H; Nordenskjöld M; Horne A; Henter JI; Meeths M; Abdelhaleem M; Weitzman S; Bryceson Y
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28184. PubMed ID: 31994322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a new disease-causing mutation of SH2D1A in a family with X-linked lymphoproliferative disease.
    Erdõs M; Uzvölgyi E; Nemes Z; Török O; Rákóczi E; Went-Sümegi N; Sümegi J; Maródi L
    Hum Mutat; 2005 May; 25(5):506. PubMed ID: 15841490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe XLP Phenotype Caused by a Novel Intronic Mutation in the SH2D1A Gene.
    Tóth B; Soltész B; Gyimesi E; Csorba G; Veres Á; Lányi Á; Kovács G; Maródi L; Erdős M
    J Clin Immunol; 2015 Jan; 35(1):26-31. PubMed ID: 25491288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.